Search

everythinglearnresearchcommunity

for

Search:↓

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Spironolactone does not increase the risk of breast cancer recurrence.

Higher cholesterol levels increase aggressive prostate cancer risk.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Raman spectroscopy could effectively guide skin cancer surgery by identifying tumor margins.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Alopecia neoplastica is hair loss from breast cancer spreading to the scalp.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.